Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
MULTICENTER STUDY
Girolamo Tartaglione, Sandro J Stoeckli, Remco de Bree, Clare Schilling, Geke B Flach, Vivi Bakholdt, Jens Ahm Sorensen, Anders Bilde, Christian von Buchwald, Georges Lawson, Didier Dequanter, Pedro M Villarreal, Manuel Florentino Fresno Forcelledo, Julio Alvarez Amezaga, Augusto Moreira, Tito Poli, Cesare Grandi, Maurizio Giovanni Vigili, Michael O'Doherty, Davide Donner, Elisabeth Bloemena, Siavash Rahimi, Benjamin Gurney, Stephan K Haerle, Martina A Broglie, Gerhard F Huber, Annelise L Krogdah, Lars R Sebbesen, Edward Odell, Luis Manuel Junquera Gutierrez, Luis Barbier, Joseba Santamaria-Zuazua, Manuel Jacome, Marie-Cecile Nollevaux, Emma Bragantini, Philippe Lothaire, Enrico M Silini, Enrico Sesenna, Giles Dolivet, Romina Mastronicola, Agnes Leroux, Isabel Sassoon, Philip Sloan, Patrick M Colletti, Domenico Rubello, Mark McGurk
PURPOSE: Nuclear imaging plays a crucial role in lymphatic mapping of oral cancer. This evaluation represents a subanalysis of the original multicenter SENT trial data set, involving 434 patients with T1-T2, N0, and M0 oral squamous cell carcinoma. The impact of acquisition techniques, tracer injection timing relative to surgery, and causes of false-negative rate were assessed. METHODS: Three to 24 hours before surgery, all patients received a dose of Tc-nanocolloid (10-175 MBq), followed by lymphoscintigraphy...
July 2016: Clinical Nuclear Medicine
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
